NCT04079543

Brief Summary

The purpose of this randomized, control study is to compare liberal vs strict nil per os (NPO) policies on patients undergoing transcatheter aortic valve replacement (TAVR) or arrhythmia ablation. The primary objective of this study is to determine if allowing clear liquids up to 2 hours prior to elective TAVR or elective arrhythmia ablation procedure improves patient satisfaction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 6, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

September 9, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2021

Completed
Last Updated

September 6, 2019

Status Verified

September 1, 2019

Enrollment Period

1 year

First QC Date

September 2, 2019

Last Update Submit

September 4, 2019

Conditions

Keywords

Nil per os (NPO)TAVRarrhythmia ablation

Outcome Measures

Primary Outcomes (1)

  • Patient Satisfaction: survey

    The primary objective is to determine if allowing clear liquids up to 2 hours prior to elective TAVR or elective arrhythmia ablation procedure improves patient satisfaction. Patient satisfaction will be determined by a patient satisfaction survey given 2 hours (+/- 2 hrs) prior to procedure. This survey will assess: thirst, hunger, headache, nausea, lightheadedness, and anxiety.

    Up to 24 hours

Secondary Outcomes (1)

  • Exploratory Analyses

    Through the end of hospitalization, usually 2 days.

Study Arms (2)

Strict NPO

OTHER

NPO after midnight. No solids or liquids after midnight.

Other: NPO past midnight

Liberal NPO

OTHER

No solids after midnight. Clear liquids up to 2 hours prior to surgery.

Other: NPO

Interventions

NPO after midnight (solids and liquids), except for a sip of water with medication.

Strict NPO
NPOOTHER

No solids after midnight. Clear liquids up to 2 hours prior to procedure. Patients can take medications with a sip of water.

Liberal NPO

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older,
  • patients planned to undergo trans-catheter aortic valve replacement or arrhythmia ablation at Stony Brook University Hospital
  • ability to provide written informed consent

You may not qualify if:

  • Age less than 18 years
  • emergency procedure, dysphasia, nutrition administered via feeding tube (NG, PEG, etc.) or intravenously (total parenteral nutrition), gastroparesis,
  • patients not alert and oriented to person, place, and date,
  • concurrent surgical procedures on the day of TAVR or arrhythmia ablation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Atkinson DJ, Romeiser JL, Almasry IO, Tannous HJ, Parikh PB, Bennett-Guerrero E. Randomized controlled trial of liberal vs. standard fasting instructions in percutaneous cardiac procedures. Perioper Med (Lond). 2023 Aug 8;12(1):44. doi: 10.1186/s13741-023-00333-z.

MeSH Terms

Conditions

Patient SatisfactionDehydration

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized (1:1) into one of the two groups: Strict NPO (NPO after midnight) or liberal NPO (clear liquids up to 2 hours prior to procedure).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiac Anesthesiologist

Study Record Dates

First Submitted

September 2, 2019

First Posted

September 6, 2019

Study Start

September 9, 2019

Primary Completion

September 9, 2020

Study Completion

September 9, 2021

Last Updated

September 6, 2019

Record last verified: 2019-09